These innovative medications , including Rybelsus, belong to a class of drugs called GLP-1 agents. Primarily developed for managing type 2 diabetes , they operate by helping the organism to secrete more insulin and curbing excessive blood sugar levels. Furthermore , their ability to support weight management has contributed to substantial interest